hepatocarcinomas develop
肝細胞癌的發展
hepatocarcinomas caused
導致肝細胞癌
primary hepatocarcinomas
原發性肝細胞癌
treating hepatocarcinomas
治療肝細胞癌
hepatocarcinomas show
肝細胞癌顯示
advanced hepatocarcinomas
晚期肝細胞癌
hepatocarcinomas with
伴有肝細胞癌
multiple hepatocarcinomas
多發性肝細胞癌
hepatocarcinomas arising
發生肝細胞癌
hepatocarcinomas associated
與肝細胞癌相關
advanced hepatocarcinomas often require multimodal treatment approaches.
肝細胞癌通常需要多模式治療方法。
the prognosis of hepatocarcinomas varies significantly depending on the stage at diagnosis.
肝細胞癌的預後根據診斷時的階段而有顯著差異。
chronic hepatitis b infection is a major risk factor for developing hepatocarcinomas.
慢性乙型肝炎感染是發展成肝細胞癌的主要風險因素。
early detection of hepatocarcinomas improves survival rates substantially.
肝細胞癌的早期檢測能顯著提高存活率。
molecular targeted therapies have shown promise in treating hepatocarcinomas.
分子靶向療法在治療肝細胞癌方面顯示出潛力。
hepatocarcinomas frequently arise in the setting of cirrhotic livers.
肝細胞癌常發生在肝硬化肝臟的背景下。
the incidence of hepatocarcinomas has been increasing globally.
肝細胞癌的發生率在全球範圍內不斷增加。
surgical resection remains the primary treatment option for early-stage hepatocarcinomas.
外科切除仍然是早期肝細胞癌的主要治療選擇。
ablation techniques are effective for small hepatocarcinomas.
消融技術對小肝細胞癌有效。
liver transplantation offers curative potential for selected hepatocarcinomas patients.
肝臟移植為某些肝細胞癌患者提供了根治的可能性。
biomarkers are being studied to improve detection of hepatocarcinomas.
生物標記物正在被研究以提高肝細胞癌的檢測。
vascular invasion is a poor prognostic indicator in hepatocarcinomas.
血管侵犯是肝細胞癌中的一個不良預後指標。
hepatocarcinomas develop
肝細胞癌的發展
hepatocarcinomas caused
導致肝細胞癌
primary hepatocarcinomas
原發性肝細胞癌
treating hepatocarcinomas
治療肝細胞癌
hepatocarcinomas show
肝細胞癌顯示
advanced hepatocarcinomas
晚期肝細胞癌
hepatocarcinomas with
伴有肝細胞癌
multiple hepatocarcinomas
多發性肝細胞癌
hepatocarcinomas arising
發生肝細胞癌
hepatocarcinomas associated
與肝細胞癌相關
advanced hepatocarcinomas often require multimodal treatment approaches.
肝細胞癌通常需要多模式治療方法。
the prognosis of hepatocarcinomas varies significantly depending on the stage at diagnosis.
肝細胞癌的預後根據診斷時的階段而有顯著差異。
chronic hepatitis b infection is a major risk factor for developing hepatocarcinomas.
慢性乙型肝炎感染是發展成肝細胞癌的主要風險因素。
early detection of hepatocarcinomas improves survival rates substantially.
肝細胞癌的早期檢測能顯著提高存活率。
molecular targeted therapies have shown promise in treating hepatocarcinomas.
分子靶向療法在治療肝細胞癌方面顯示出潛力。
hepatocarcinomas frequently arise in the setting of cirrhotic livers.
肝細胞癌常發生在肝硬化肝臟的背景下。
the incidence of hepatocarcinomas has been increasing globally.
肝細胞癌的發生率在全球範圍內不斷增加。
surgical resection remains the primary treatment option for early-stage hepatocarcinomas.
外科切除仍然是早期肝細胞癌的主要治療選擇。
ablation techniques are effective for small hepatocarcinomas.
消融技術對小肝細胞癌有效。
liver transplantation offers curative potential for selected hepatocarcinomas patients.
肝臟移植為某些肝細胞癌患者提供了根治的可能性。
biomarkers are being studied to improve detection of hepatocarcinomas.
生物標記物正在被研究以提高肝細胞癌的檢測。
vascular invasion is a poor prognostic indicator in hepatocarcinomas.
血管侵犯是肝細胞癌中的一個不良預後指標。
Explore frequently searched vocabulary
Want to learn vocabulary more efficiently? Download the DictoGo app and enjoy more vocabulary memorization and review features!
Download DictoGo Now